222 related articles for article (PubMed ID: 16783169)
1. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment.
Counts SE; Nadeem M; Lad SP; Wuu J; Mufson EJ
J Neuropathol Exp Neurol; 2006 Jun; 65(6):592-601. PubMed ID: 16783169
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal drebrin loss in mild cognitive impairment.
Counts SE; He B; Nadeem M; Wuu J; Scheff SW; Mufson EJ
Neurodegener Dis; 2012; 10(1-4):216-9. PubMed ID: 22310934
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
[TBL] [Abstract][Full Text] [Related]
4. Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease.
Mufson EJ; Wuu J; Counts SE; Nykjaer A
Neurosci Lett; 2010 Mar; 471(3):129-33. PubMed ID: 20085800
[TBL] [Abstract][Full Text] [Related]
5. Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction.
Reddy PH; Mani G; Park BS; Jacques J; Murdoch G; Whetsell W; Kaye J; Manczak M
J Alzheimers Dis; 2005 Apr; 7(2):103-17; discussion 173-80. PubMed ID: 15851848
[TBL] [Abstract][Full Text] [Related]
6. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease.
Counts SE; Nadeem M; Wuu J; Ginsberg SD; Saragovi HU; Mufson EJ
Ann Neurol; 2004 Oct; 56(4):520-31. PubMed ID: 15455399
[TBL] [Abstract][Full Text] [Related]
7. Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer's Disease.
Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
J Alzheimers Dis; 2018; 62(1):115-131. PubMed ID: 29439356
[TBL] [Abstract][Full Text] [Related]
8. Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobe.
Huang J; Friedland RP; Auchus AP
AJNR Am J Neuroradiol; 2007; 28(10):1943-8. PubMed ID: 17905894
[TBL] [Abstract][Full Text] [Related]
9. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment.
Assaraf MI; Diaz Z; Liberman A; Miller WH; Arvanitakis Z; Li Y; Bennett DA; Schipper HM
J Neuropathol Exp Neurol; 2007 May; 66(5):389-98. PubMed ID: 17483696
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
11. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease.
Sze CI; Troncoso JC; Kawas C; Mouton P; Price DL; Martin LJ
J Neuropathol Exp Neurol; 1997 Aug; 56(8):933-44. PubMed ID: 9258263
[TBL] [Abstract][Full Text] [Related]
12. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
[TBL] [Abstract][Full Text] [Related]
13. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease.
Scheff SW; Price DA; Ansari MA; Roberts KN; Schmitt FA; Ikonomovic MD; Mufson EJ
J Alzheimers Dis; 2015; 43(3):1073-90. PubMed ID: 25147118
[TBL] [Abstract][Full Text] [Related]
14. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
Bokde AL; Lopez-Bayo P; Meindl T; Pechler S; Born C; Faltraco F; Teipel SJ; Möller HJ; Hampel H
Brain; 2006 May; 129(Pt 5):1113-24. PubMed ID: 16520329
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease.
Masliah E; Mallory M; Alford M; DeTeresa R; Hansen LA; McKeel DW; Morris JC
Neurology; 2001 Jan; 56(1):127-9. PubMed ID: 11148253
[TBL] [Abstract][Full Text] [Related]
16. Decreases in soluble alpha-synuclein in frontal cortex correlate with cognitive decline in the elderly.
Wang DS; Bennett DA; Mufson E; Cochran E; Dickson DW
Neurosci Lett; 2004 Apr; 359(1-2):104-8. PubMed ID: 15050722
[TBL] [Abstract][Full Text] [Related]
17. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease.
Berchtold NC; Sabbagh MN; Beach TG; Kim RC; Cribbs DH; Cotman CW
Neurobiol Aging; 2014 Sep; 35(9):1961-72. PubMed ID: 24786631
[TBL] [Abstract][Full Text] [Related]
18. Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease.
Lai MK; Tsang SW; Alder JT; Keene J; Hope T; Esiri MM; Francis PT; Chen CP
Psychopharmacology (Berl); 2005 May; 179(3):673-7. PubMed ID: 15551121
[TBL] [Abstract][Full Text] [Related]
19. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome.
Shim KS; Lubec G
Neurosci Lett; 2002 May; 324(3):209-12. PubMed ID: 12009525
[TBL] [Abstract][Full Text] [Related]
20. Cognitive decline in AD and mild cognitive impairment is associated with global brain damage.
Van Der Flier WM; Van Den Heuvel DM; Weverling-Rijnsburger AW; Spilt A; Bollen EL; Westendorp RG; Middelkoop HA; Van Buchem MA
Neurology; 2002 Sep; 59(6):874-9. PubMed ID: 12297570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
